MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.clgc.2017.01.013

Медицинская библиотека · Clinical genitourinary cancer · 2017

"In-bore" MRI-guided Prostate Biopsy Using an Endorectal Nonmagnetic Device: A Prospective Study of 70 Consecutive Patients.

Schiavina Riccardo, Vagnoni Valerio, D'Agostino Daniele, Borghesi Marco, Salvaggio Antonio, Giampaoli Marco, Pultrone Cristian V, Saraceni Giacomo, Gaudiano Caterina, Vigo Mario, Bianchi Lorenzo, Dababneh Hussam, La Manna Gaetano, Chessa Francesco, Romagnoli Daniele, Martorana Giuseppe, Brunocilla Eugenio, Porreca Angelo

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

We investigated the diagnostic performance of in-bore endorectal magnetic resonance imaging-guided biopsy (MRI-GB) with a 1.5-T MRI scanner using a 32-channel coil in patients with suspected prostate cancer (PCa).

PATIENTS AND

METHODS

Seventy patients with ≥ 1 suspicious area found on the preliminary multiparametric MRI scan were enrolled. The index lesion was defined as the lesion with the greatest Prostate Imaging Reporting and Data System, version 2 (PIRADS-v2), score. MRI-GBs were performed with a nonmagnetic biopsy device, needle guide, and titanium double-shoot biopsy gun with dedicated software for needle tracking. Clinically significant PCa was defined as the presence of Gleason score ≥ 7 in the biopsy specimen.

RESULTS

Seventy index lesions were scheduled for MRI-GB. The median PIRADS-v2 score and the median number of cores per patient was 4 of 5 (interquartile range, 3-5) and 2 (interquartile range, 1-3), respectively. The PCa detection rate was 45.7%. Of the 70 patients, 24 (75%) had clinically significant PCa, with a significant correlation between the PIRADS-v2 score and the Gleason score in the MRI-GB cores (r = 0.839; 95% confidence interval, 0.535-0.951; P = .003). According to the PIRADs-v2 scheme, the proportion of PCa in the central and anterior regions of the gland was greater in the entire population and in the subgroup of patients with a history of negative transrectal ultrasound-guided biopsy findings (P ≤ .01 for all). On multivariate analysis, a PIRADS-v2 score of 5 of 5 correlated significantly with the likelihood of PCa at biopsy (hazard ratio, 4.69; 95% confidence interval, 0.92-23.74; P = .04). No major complications were recorded.

CONCLUSION

MRI-GB has a high detection rate for PCa, especially for lesions located in the central and anterior regions of the prostate.

Для цитирования: Schiavina Riccardo, Vagnoni Valerio, D'Agostino Daniele, Borghesi Marco, Salvaggio Antonio, Giampaoli Marco, Pultrone Cristian V, Saraceni Giacomo, Gaudiano Caterina, Vigo Mario, Bianchi Lorenzo, Dababneh Hussam, La Manna Gaetano, Chessa Francesco, Romagnoli Daniele, Martorana Giuseppe, Brunocilla Eugenio, Porreca Angelo. "In-bore" MRI-guided Prostate Biopsy Using an Endorectal Nonmagnetic Device: A Prospective Study of 70 Consecutive Patients.. Clinical genitourinary cancer. 2017. DOI: 10.1016/j.clgc.2017.01.013.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.